Evaluation of the mutation profile detected in lung adenocarcinomas with different N status
Open Access
- 9 June 2025
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 26 (1) , 1-8
Abstract
Background: Lymph node status is the most important prognostic factor in resectable non-small cell lung cancer (NSCLC). Considering the critical importance of lymph nodes, determining N status and related molecular biomarkers may contribute to the literature for understanding the pathogenesis in the early stage and shedding light on treatment. Materials and methods: 71 patients with lung adenocarcinoma and lymph node metastasis were included. Next-generation sequencing (NGS) was performed on metastatic lymph samples at the Molecular Pathology Laboratory of Aydın Adnan Menderes University Faculty of Medicine, Turkey. The gender, age, N Status and mutation results were analyzed. Results: Mutation was detected in 46 patients (69%). The most frequently observed mutations included Tumor Protein 53 (TP53) (17, 23.9%), Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) (11, 15.5%), Epidermal Growth Factor Receptor (EGFR) (10, 14.1%), Phosphatase and tension homolog (PTEN) (9, 12.7%), Neurofibromatosis type 1 (NF1) (5, 7%) and B-Raf proto-oncogene, serine/threonine kinase (BRAF) (3, 4.2%). A statistically significant increase in mutation frequency was observed with advancing N stage (p < 0.01). Additionally, the number of patients with multiple mutation associations also increased with higher N stages. Although the increase in TP53, PTEN, and KRAS mutation rates with higher N stages did not reach statistical significance, a correlation was observed (p = 0.09, p = 0.07, and p = 0.06, respectively). Notably, KRAS G12C mutations were exclusively detected in advanced N stages. Conclusion: Our study reveals the mutation profile in lymph node metastases in different locations in patients with lung adenocarcinoma. We hope that this new information will contribute to the literature on early prevention of distant metastases.Keywords
This publication has 26 references indexed in Scilit:
- The impact of pathology grossing protocol measures to improve pathologic nodal staging in lung cancerCancer Treatment and Research Communications, 2021
- Current therapy of KRAS-mutant lung cancerCancer and Metastasis Reviews, 2020
- Next generation sequencing in lung cancer: An initial experience from IndiaCurrent Problems in Cancer, 2020
- The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasisClinical & Experimental Metastasis, 2019
- Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLCJournal of Thoracic Oncology, 2019
- PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cellsLung Cancer, 2019
- Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non–Small Cell Lung Cancer After Resection With Curative IntentJAMA Oncology, 2018
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerThe Journal of Molecular Diagnostics, 2017
- The Eighth Edition Lung Cancer Stage ClassificationChest, 2017
- Role of lymphatic vasculature in regional and distant metastasesMicrovascular Research, 2014